Tumor necrosis factor alpha expression in the spinal cord of human T-cell lymphotrophic virus type I associated myelopathy/tropical spastic paraparesis patients

References

• Brosnan C F, Selmaj K, Raine C S. Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol 1988; 18: 87–94
   PubMed Web of Science ®Google Scholar
• Cannella B, Raine C S. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995; 37: 424–435
   PubMed Web of Science ®Google Scholar
• Hoffman P M, Dhib-Jalbut S, Mikovits J A, Robbins D S, Wolf A L, Bergey G K, Lohrey N C, Weislow O S, Ruscetti F W. Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures. Proc Natl Acad Sci USA 1992; 89: 11784–11788
   Google Scholar
• Hofman F M, Hinton D R, Johnson K, Merrill J E. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989; 170: 607–612
   PubMed Web of Science ®Google Scholar
• Hollsberg P, Hafler D A. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 1993; 328: 1173–1182
   PubMed Web of Science ®Google Scholar
• Ijichi S, Eiraku N, Osame M, Izumo S, Kubota R, Maruyama I, Matsumoto M, Niimura T, Sonoda S. Activated T lymphocytes in cerebrospinal fluid of patients with HTLV-I-associated myelopathy (HAM/TSP). J Neuroimmunol 1989; 25: 251–254
   Google Scholar
• Jacobson S, Shida H, McFarlin D E, Fauci A S, Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 1990; 348: 245–24
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Hamamoto Y, Yamamato N. Production of tumor necrosis factors by human Tcell lines infected by HTLV-1 may cause their high susceptibility to human immunodeficiency virus infection. Med Microbiol Immunol 1990; 179: 115–122
   Google Scholar
• Kuroda Y, Matsui M, Takashima H, Kurohara K. Granulocyte-macrophage colony-stimulating factor and interleukin-1 increase in cerebrospinal fluid, but not in serum, of HTLV-I-associated myelopathy. J Neuroimmunol 1993; 45: 133–136
   Google Scholar
• Kuroda Y, Matsui M. Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopadiy. J Neuroimmunol 1993; 42: 223–226
   PubMedGoogle Scholar
• Lahdevirta J, Maury C P, Teppo A, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85: 289–291
   PubMed Web of Science ®Google Scholar
• Lal R B, Rudolph D L. Constitutive production of interleukin-6 and tumor necrosis factor-alpha from spontaneously proliferating T cells in patients with human T-cell lymphotropic virus type-I/II. Blood 1991; 78: 571–574
   PubMed Web of Science ®Google Scholar
• Lehky T J, Fox C H, Koenig S, Levin M C, Flerlage N, Izumo S, Sato E, Raine C S, Osame M, Jacobson S. Detection of Human T-Lymphotropic Virus Type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol 1995; 47: 167–175
   Google Scholar
• Levin M C, Fox R J, Lehky T, Walter M, Fox C H, Flerlage N, Bamford R, Jacobson S. Polymerase chain reaction/ in situ hybridization detection of HTLV-tax proviral DNA in peripheral blood lymphocytes of patients with HTLV-I associated neurologic disease. J Virol 1996; 70, in press
   Google Scholar
• Lieberman A P, Pitha P M, Shin H S, Shin M L. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotrophic virus. Proc Natl Acad Sci USA 1989; 86: 6348–6352
   PubMed Web of Science ®Google Scholar
• Mintz M, Rapaport R, Oleske J M, Connor E M, Koenigsberger M R, Denny T, Epstein L G. Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. Am J Dis Child 1989; 143: 771–774
   Google Scholar
• Moore G RW, Traugott U, Scheinberg L C, Raine C S. Tropical Spastic Paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination?. Ann Neurol 1989; 26: 523–530
   Google Scholar
• Nakamura S, Nagano I, Yoshioka M, Shimazaki S, Onodera J, Kogure K. Detection of tumor necrosis factor-alpha-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy. N Neuroimmunol 1993; 42: 127–130
   PubMed Web of Science ®Google Scholar
• Nishimoto N, Yoshizaki K, Eiraku N, Machigashira K, Tagoh H, Ogata A, Kuritani T, Osame M, Kishimoto T. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopadiy/ tropical spastic paraparesis. J Neurol Sci 1990; 97: 183–193
   PubMed Web of Science ®Google Scholar
• Ohbo K, Sugamura K, Sekizawa T, Kogure K. Interleukin-6 in cerebrospinal fluid of HTLV-Iassociated myelopathy. Neurology 1991; 41: 594–595
   PubMed Web of Science ®Google Scholar
• Selmaj K, Raine C S, Cannella B, Brosnan C F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991; 87: 949–954
   PubMed Web of Science ®Google Scholar
• Selmaj K W, Raine C S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988; 23: 339–346
   PubMed Web of Science ®Google Scholar
• Tendler C L, Greenberg S J, Burton J D, Danielpour D, Kim S J, Blattner W A, Manns A, Waldmarm T A. Cytokine induction in HTLV-I associated myelopadiy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral padiogenesis. J Cell Biochem 1991; 46: 302–311
   PubMedGoogle Scholar
• Tschachler E, Robert-Guroff M, Gallo R C, Reitz M S, Jr. Human T-lymphotropic virus I-infected T cells constitutively express lymphotoxin in vitro. Blood 1989; 73: 194–201
   PubMed Web of Science ®Google Scholar
• Tyor W R, Glass J D, Baumrind N, McArthur J C, Griffin J W, Becker P S, Griffin D E. Cytokine expression of macrophages in HTV-1-associated vacuolar myelopathy. Neurology 1993; 43: 1002–1009
   Google Scholar
• Umehara F, Izumo S, Nakagawa M, Ronquillo A T, Takahashi K, Matsumuro K, Sato E, Osame M. Immunocytochemical analysis of the cellular infiltrates in the spinal cord lesions in HTLV-I associated myelopathy. J Neuropathol and Exp Neurol 1993; 52: 424–430
   Google Scholar
• Umehara F, Izumo S, Ronquillo A T, Matsumuro K, Sato E, Osame M. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopadiy. J Neuropath Exp Neurol 1994; 53: 72–77
   PubMedGoogle Scholar
• Waage A, Halstensen A, Shalaby R, Brandtaeg P, Espevik T. Local production of tumor necrosis factor α, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med 1989; 170: 1859–1867
   PubMed Web of Science ®Google Scholar
• Wang A M, Creasey A A, Ladner M B, Lin L S, Strickler J, Van Arsdell J N, Yamamoto R, Mark D F. Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 1985; 228: 149–154
   PubMed Web of Science ®Google Scholar
• Watanabe H, Nakamura T, Nagasato K, Shirabe S, Ohishi K, Ichinose K, Nishiura Y, Chiyoda S, Tsujihata M, Nagataki S. Exaggerated messenger RNA expression of inflammatory cytokines in human T-cell leukemia virus type I-associated myelopadiy. Arch Neurol 1995; 52: 276–280
   Google Scholar
• Wu E, Dickson D W, Jacobson S, Raine C S. Neuroaxonal dystrophy in HTLV-I-associated myelopathy/tropical spastic paraparesis: neuro pathologic and neuroimmunologic correlations. Acta Neuropathol 1993; 86: 224–235
   PubMedGoogle Scholar